The short version of ACTH(4-10) fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-29 and is reviewed periodically as new material appears.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide (ACTH fragment analog) | Not a steroid; does not belong to the melanocortin agonist drugs by marketing category |
| Molecular formula | C37H51N9O10S (commonly cited) | Reported values vary slightly with salt and counter-ion content |
| Appearance | White to off-white lyophilized powder | A single batch may appear as a loose cake or fluffy solid |
| Solubility | Freely soluble in water and aqueous buffer | Stock solutions are usually prepared in sterile water or saline |
| Typical storage | −20 °C or below, desiccated and protected from light | Seal opened vials promptly to limit moisture uptake |
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
ECD with UV-based activation increases the top-down MS sequence coverage of disulfide bond containing proteins and cleaves a disulfide bond homolytically to produce two separated thiol radicals. This technique was observed with insulin and ribonuclease, which led them to cleave up to three disulfide bonds and increase the sequence coverage.
Concurrently to the oxygen barrier property, the permeability of water vapor through a food packaging system should be minimized to effectively prevent physical and chemical changes connected to an excessive moisture content. The moisture barrier properties of a material can be assessed by measuring the water vapor transmission rate (WVTR), which can be defined as the amount of water vapor per unit of area and unit of time passing through the packaging film. The WVTR measurements, like the OTR, adhere to the standards for standardized tests, as outlined in the ASTM E96 (standard methods for water vapor transmission of materials). An impermeable test dish (such as a stainless steel cup) and a test chamber, where temperature and relative humidity (RH) can be adjusted in accordance with the standard specification, make up the basic instrumentation used in such tests.
Since the turn of the millennium, the Russian Armed Forces have been issued the Individual Food Rations (Russian: Индивидуальный рацион питания/ИРП, romanized: Individual'nyi Ratsion Pitaniya (IRP)), a new self-contained ration, containing the whole daily food intake for an individual soldier in the field. However, in its most frequent form it is not dietary complete, and is intended only as a stop-gap measure to be issued until the normal supply lines (with their field kitchens) are established and the hot food delivery started, to be issued for no more than six days straight. The Ministry of Defence does not strictly prescribe the contents of the ration, only some basic packaging and inventory requirements, so every producer issues their own version. Most commonly it is packaged into a sturdy plastic blister box (nicknamed "The Frog" in the field for its olive-green color), or plastic-sealed cardboard box that contains five to six entrees in laminated foil cans or retort pouches, four to six pack of crackers or preserved bread, two to three dessert items in form of a spread or fruit bar, four beverage concentrate pouches, some seasonings (salt, pepper, sugar, ketchup), and various sundry items like sanitizing wipes/paper towels, spoons, can opener, four hexamine fuel tablets, folding heater, matches and water purifier tablets.
=== Agriculture === Natural freshwater diatomaceous earth is used in agriculture for grain storage as an anticaking agent, as well as an insecticide. It is approved by the U.S. Food and Drug Administration as a feed additive to prevent caking. Some believe it may be used as a natural anthelmintic (dewormer), although studies have not shown it to be effective. Some farmers add it to their livestock and poultry feed to prevent the caking of feed. "Food-Grade Diatomaceous Earth" is widely available in agricultural feed supply stores. Freshwater diatomite can be used as a growing medium in hydroponic gardens. It is also used as a growing medium in potted plants, particularly as bonsai soil. Bonsai enthusiasts use it as a soil additive, or pot a bonsai tree in 100% diatomaceous earth. In vegetable gardening it is sometimes used as a soil conditioner, because like perlite, vermiculite, and expanded clay, it retains water and nutrients, while draining fast and freely, allowing high oxygen circulation within the growing medium.
(WINNER) The contestant won the whole competition. ‡ The contestant won the Pre-Heat challenge. (WIN) The contestant won the Main Heat challenge. (HIGH) The contestant had one of the best dishes for that week. (IN) The contestant performed well enough to move on to the next week. (LOW) The contestant had one of the bottom dishes for that week, but was not eliminated. (OUT) The contestant was eliminated for worst dish.
Sources: en.wikipedia.org
The tree's bark is dark brown to gray. It splits lengthwise and the inside is reddish brown. The tree's wood is dark reddish brown with a yellow center. It is very dense, durable and strong, having a density of about 1.11 g/cm3. Mimosa tenuiflora does very well after a forest fire, or other major ecological disturbance. It is a prolific pioneer plant. It drops its leaves on the ground, continuously forming a thin layer of mulch and eventually humus. Along with its ability to fix nitrogen, the tree conditions the soil, making it ready for other plant species to come along.
On July 7, 2010, Noriega was convicted by the 11th chamber of the Tribunal Correctionnel de Paris and sentenced to seven years in jail. The prosecutor in the case had sought a ten-year prison term. In addition, the court ordered the seizure of €2.3 million (approximately U.S. $3.6 million) that had long been frozen in Noriega's French bank accounts.
=== Use of other researchers' data === Watson and Crick's use of DNA X-ray diffraction data collected by Franklin and Wilkins has generated an enduring controversy. It arose from the fact that some of Franklin's unpublished data were used without her knowledge or consent by Watson and Crick in their construction of the double helix model of DNA. Of the four DNA researchers, only Franklin had a degree in chemistry; Wilkins and Crick had backgrounds in physics, Watson in biology.
== Release == Lost Coast was released on October 27, 2005, as a free download for owners of Half-Life 2 on Steam. Valve announced on May 30, 2007, that Lost Coast, along with Half-Life 2: Deathmatch, would be made available for free to owners of ATI Radeon cards. It was later released without charge to Nvidia graphics card owners along with Half-Life 2: Deathmatch, Peggle Extreme, and the first eleven levels of Portal. In 2024, the 20th anniversary of Half-Life 2, Valve updated Half-Life 2 to incorporate Lost Coast and other features.
Sources: en.wikipedia.org
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.
It was developed in the Soviet Union during the early 1980s by groups at the Institute of Molecular Genetics in Moscow. Russian approval for intranasal use followed, and it has been marketed there since. Western laboratories encountered it mainly through translated literature and, later, through online research-chemical trade.
It holds a Russian registration as a prescription nasal product but has no approval from the European Medicines Agency or the United States Food and Drug Administration. Buyers outside Russia usually receive material sold strictly for laboratory research. That distinction matters because research-grade and pharmaceutical-grade products carry different documentation and testing expectations.
The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.